Abstract
Olanzapine is an atypical antipsychotic drug used in treating schizophrenia. Adverse effects related to its use, are obesity, hyperlipidemia, type II diabetes mellitus and hypertension, may result in development of metabolic syndrome. Thus, this study aims to investigate the effect of prolonged use of olanzapine in schizophrenic patients for the parameters: total cholesterol, LDL choleste…